financetom
Business
financetom
/
Business
/
Walmart CEO Doug McMillon to Retire in January; US Operations Head Named Successor
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walmart CEO Doug McMillon to Retire in January; US Operations Head Named Successor
Nov 14, 2025 8:02 AM

10:33 AM EST, 11/14/2025 (MT Newswires) -- Walmart ( WMT ) said Friday that Doug McMillon will retire as chief executive of the retail giant at the end of January, with the head of its US operations and long-time company executive set to succeed him.

John Furner will take over from McMillon in the top role, effective Feb. 1. Furner, who currently serves as CEO of Walmart US and has been with the company for more than three decades, was also elected to its board of directors, effective immediately.

"John Furner is the right leader to guide Walmart ( WMT ) into our next chapter of growth and transformation," Chairman Greg Penner said in a statement. "John's six-year leadership of our Walmart US business during a time of rapid change, marked by digital acceleration and strong associate engagement, has positioned us for continued success."

McMillon, who is set to retire on Jan. 31, will remain on Walmart's ( WMT ) board until its next annual shareholders meeting in June to ensure a smooth transition and will remain an advisor to Furner through fiscal 2027, according to the company.

Walmart's ( WMT ) shares were down 1.4% in Friday trade. The stock has gained about 12% so far this year.

The company is scheduled to release its latest quarterly results next week. In August, the retailer reported fiscal second-quarter earnings below Wall Street's estimates, but lifted its full-year outlook amid expectations for continued market share gains.

"I am deeply honored by the trust the board and family have placed in me to lead Walmart ( WMT )," Furner said. "As we enter a new retail era fueled by innovation and AI, our purpose and our people will continue to guide us."

The company said it plans to appoint a successor to Furner as CEO of Walmart US before the end of its fiscal year 2026.

Price: 100.97, Change: -1.57, Percent Change: -1.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug
Update: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug
Jun 20, 2025
09:26 AM EDT, 06/20/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Thursday it was planning to appeal against the UK's National Institute for Health and Care Excellence's, or NICE's, decision not to reimburse the cost of Alzheimer's drug Kisunla under the National Health Service. The drugmaker said the regulator's decision is unreasonable based on the evidence submitted by...
BlackBerry's Valuation to Remain Discounted on 'Conservative' Guidance, RBC Says
BlackBerry's Valuation to Remain Discounted on 'Conservative' Guidance, RBC Says
Jun 20, 2025
09:16 AM EDT, 06/20/2025 (MT Newswires) -- BlackBerry's (BB) conservative guidance has set the bar low for fiscal Q1 earnings and the company's valuation is likely to remain discounted, pending improved visibility to sustained growth, RBC Capital Markets said in a Friday note. The company's fiscal Q1 results could exceed RBC's and consensus estimates, as the macro environment has been...
Actuate Therapeutics Identifies Biomarkers in Treatment of Metastatic Pancreatic Cancer in Phase 2 Trial
Actuate Therapeutics Identifies Biomarkers in Treatment of Metastatic Pancreatic Cancer in Phase 2 Trial
Jun 20, 2025
09:17 AM EDT, 06/20/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Friday that its phase 2 trial of elraglusib in combination with gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer demonstrated the use of machine learning and statistical models to predict overall survival based on pre-dose plasma biomarkers. The analysis identified seven biomarkers as uniquely significant predictors of favorable survival...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved